DNA methylation: New therapeutic implications for hepatic fibrosis

Cellular Signalling

Volumn 25, Issue 1, 2013, Pages 355-358

  Bian, Er Bao ^a   Huang, Cheng ^a   Wang, Hua ^a   Wu, Bao Ming ^a   Zhang, Lei ^a   Lv, Xiong wen ^a   Li, Jun ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

DNA methylation; Hepatic stellate cell; Liver fibrosis; Signaling pathway

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ALPHA SMOOTH MUSCLE ACTIN; DESMIN; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; HISTONE DEACETYLASE; METHYL CPG BINDING PROTEIN 2; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PLATELET DERIVED GROWTH FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

CELL DIFFERENTIATION; CELL GROWTH; CELL SURVIVAL; CPG ISLAND; DNA DEGRADATION; DNA METHYLATION; EPIGENETICS; EXTRACELLULAR MATRIX; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE SILENCING; HETEROZYGOSITY; IMMUNOPRECIPITATION; LEUKEMIA; LIVER FIBROSIS; MOLECULAR DYNAMICS; MYELODYSPLASTIC SYNDROME; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; STELLATE CELL; TUMOR SUPPRESSOR GENE; UPREGULATION;

DNA; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; ENZYME INHIBITORS; EPIGENESIS, GENETIC; EXTRACELLULAR MATRIX; HEPATIC STELLATE CELLS; HUMANS; I-KAPPA B PROTEINS; LIVER CIRRHOSIS; SIGNAL TRANSDUCTION;

EID: 84870245587     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2012.10.007     Document Type: Review

References (52)

1. Gao B., Bataller R. Gastroenterology 2011, 141(5):1572-1585.
2. Olaso E., Friedman S.L. Journal of Hepatology 1998, 29(5):836-847.
3. Friedman S.L. Journal of Gastroenterology and Hepatology 2006, 21(Suppl. 3):S79-S83.
4. Muddu A.K., et al. The International Journal of Biochemistry & Cell Biology 2007, 39(4):695-714.
5. Elsharkawy A.M., Oakley F., Mann D.A. Apoptosis 2005, 10(5):927-939.
6. Friedman S.L., et al. Proceedings of the National Academy of Sciences of the United States of America 1985, 82(24):8681-8685.
7. Takahara Y., et al. World Journal of Gastroenterology 2006, 12(40):6473-6499.
8. Baylin S.B. Nature Clinical Practice Oncology 2005, 2(Suppl. 1):S4-S11.
9. Galm O., Herman J.G., Baylin S.B. Blood Reviews 2006, 20(1):1-13.
10. Rothhammer T., Bosserhoff A.K. Pigment Cell Research 2007, 20(2):92-111.
11. Dwivedi R.S., et al. Kidney International 2011, 79(1):23-32.
12. Herman J.G., et al. Proceedings of the National Academy of Sciences of the United States of America 1994, 91(21):9700-9704.
13. Jones P.A., Laird P.W. Nature Genetics 1999, 21(2):163-167.
14. Fuks F., et al. Nature Genetics 2000, 24(1):88-91.
15. Fuks F., et al. EMBO Journal 2001, 20(10):2536-2544.
16. Dickstein J., et al. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(21):9783-9788.
17. Robertson K.D., et al. Nature Genetics 2000, 25(3):338-342.
18. Rountree M.R., Bachman K.E., Baylin S.B. Nature Genetics 2000, 25(3):269-277.
19. De Carvalho D.D., You J.S., Jones P.A. Trends in Cell Biology 2010, 20(10):609-617.
20. Brenner C., Fuks F. Current Topics in Microbiology and Immunology 2006, 301:45-66.
21. Turek-Plewa J., Jagodzinski P.P. Cellular and Molecular Biology Letters 2005, 10(4):631-647.
22. del Senno L., et al. Cancer Detection and Prevention 1986, 9(1-2):9-15.
23. Mack G.S. Journal of the National Cancer Institute 2006, 98(20):1443-1444.
24. Szyf M. Frontiers in Bioscience 2001, 6:D599-D609.
25. Blobe G.C., Schiemann W.P., Lodish H.F. The New England Journal of Medicine 2000, 342(18):1350-1358.
26. Mann D.A., Mann J. Journal of Gastroenterology and Hepatology 2008, 23(Suppl. 1):S108-S111.
27. Friedman S.L. Gastroenterology 2008, 134(6):1655-1669.
28. Friedman S.L. Physiological Reviews 2008, 88(1):125-172.
29. Rippe R.A., Brenner D.A. Gastroenterology 2004, 127(4):1260-1262.
30. Gelato K.A., Fischle W. Biological Chemistry 2008, 389(4):353-363.
31. Quina A.S., Buschbeck M., Di Croce L. Biochemical Pharmacology 2006, 72(11):1563-1569.
32. Bian E.B., et al. Toxicology and Applied Pharmacology 2012, 264(1):13-22.
33. Tao H., et al. Toxicology 2011, 290(2-3):327-333.
34. Biniszkiewicz D., et al. Molecular and Cellular Biology 2002, 22(7):2124-2135.
35. Bechtel W., et al. Nature Medicine 2010, 16(5):544-550.
36. Cheung H.H., et al. Birth Defects Research. Part C, Embryo Today: Reviews 2009, 87(4):335-350.
37. Kimura H., Shiota K. Journal of Biological Chemistry 2003, 278(7):4806-4812.
38. Mann J., et al. Cell Death and Differentiation 2007, 14(2):275-285.
39. Kadesch T. Current Opinion in Genetics and Development 2004, 14(5):506-512.
40. Kokura K., et al. Journal of Biological Chemistry 2001, 276(36):34115-34121.
41. Stancheva I., et al. Molecular Cell 2003, 12(2):425-435.
42. Marra F., et al. Hepatology 1999, 30(4):951-958.
43. Reif S., et al. Journal of Biological Chemistry 2003, 278(10):8083-8090.
44. Downward J. Nature Reviews. Cancer 2003, 3(1):11-22.
45. Mitin N., Rossman K.L., Der C.J. Current Biology 2005, 15(14):R563-R574.
46. Kolfschoten I.G., et al. Cell 2005, 121(6):849-858.
47. Gressner A.M., et al. Frontiers in Bioscience 2002, 7:d793-d807.
48. Liu Y., et al. Laboratory Investigation 2009, 89(10):1152-1160.
49. Phuong N.H., Kreinovich V. International Journal of Medical Informatics 2001, 62(2-3):165-173.
50. Guanti G., et al. Human Molecular Genetics 2000, 9(2):283-287.
51. Hino R., et al. Cancer Research 2009, 69(7):2766-2774.
52. Kato M., et al. Nature Cell Biology 2009, 11(7):881-889.